Hershey, PA, United States of America

Gregory R Jackson

This inventor holds 27 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Ophthalmic Testing. Top assignees: Maculogix, Inc., The UAB Research Foundation (The University of Alabama at Birmingham), Lumithera Diagnostics, Inc.. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory R Jackson. Retrieved from https://idiyas.com/inventor/gregory-r-jackson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 92.6

 

 

Average Co-Inventor Count = 3.1

ph-index = 10

Forward Citations = 230(Granted Patents)


Location History:

  • Alabasta, AL (US) (2009)
  • Alabaster, AL (US) (2010)
  • Hershey, PA (US) (2014 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Ophthalmic Testing
Photobleaching
Ocular Measurement
Headset
Light Seal
Measurement System
Graphical User Interface
Interface Unit
Dark Adaptation
Testing Methods
Wearable Device
Measurement Apparatus
27 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Gregory R Jackson

Introduction

Gregory R Jackson, located in Hershey, PA, is an eminent inventor known for his significant contributions to the field of ophthalmic testing and measurement. With a remarkable portfolio of 27 patents, he has continually pushed the boundaries of innovation, particularly in methods and apparatuses that enhance diagnostic testing in ophthalmology.

Latest Patents

Jackson’s latest patents reflect his commitment to advancing ophthalmic technologies. One of his notable inventions is a system for conducting ophthalmic diagnostic tests. This innovative head-wearable device is designed to administer tests while isolating at least one eye of the subject from ambient light, thereby increasing the accuracy and reliability of test results. Furthermore, his improved photobleaching method offers enhanced techniques for psychophysical assessment, particularly in measuring dark adaptation. This method involves specific improvements, such as the use of tailored light wavelengths and controlled light intensity, to optimize the photobleaching process, making it more efficient for researchers and clinicians alike.

Career Highlights

Over the years, Jackson has worked with leading organizations such as Maculogix, Inc. and The UAB Research Foundation. His experience in these institutions has significantly influenced his research and development, allowing him to collaborate on various innovative projects that have direct applications in ophthalmic diagnostics.

Collaborations

Throughout his career, Jackson has partnered with distinguished colleagues, including David E Beecher and Nathan Smith. These collaborations have not only enriched his inventions but also fostered a collaborative environment for advancing research in ophthalmic technologies.

Conclusion

Gregory R Jackson serves as a testament to the impact of innovation in medicine, specifically ophthalmology. His extensive patent portfolio and ongoing research continue to pave the way for advancements that benefit both clinicians and patients. As he further explores the intersections of technology and eye health, the future of ophthalmic testing is poised for even greater innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…